Molecular pathways mediating quiescence and resistance in leukaemia stem cells in acute myeloid leukaemia. [ 2008 - 2011 ]

Research Grant

Researchers: A/Pr Steven Lane (Principal investigator)

Brief description Acute myeloid leukaemia (AML) is a devastating cancer of the blood and bone marrow which is rapidly fatal unless effectively treated with chemotherapy. AML is caused by genetic events that alter normal blood stem cells to give them a growth and survival advantage and also may confer resistance to chemotherapy in some cases. We will evaluate and target the mechanism of this resistance in laboratory models. This information can then be used to design new treatments to improve outcomes in AML.

Funding Amount $AUD 100,381.00

Funding Scheme NHMRC Postgraduate Scholarships

Notes Medical Postgraduate Scholarship